Back to today’s briefing

Story perspectives

Eli Lilly Launches Oral GLP-1 Pill Foundayo in UK

8/25/2026

26 4 Full Breakdown

Summary

Lilly Launches Pill

Eli Lilly launched the oral GLP-1 pill Foundayo in the United Kingdom on August 10, 2026.
Foundayo became available via private prescriptions at UK pharmacies on August 24, 2026.
Foundayo costs £100-£120 per month, compared with Lilly’s Mounjaro injection at £330.
NICE will decide on NHS coverage for Foundayo by 18 November 2026.
Pharmacists warned counterfeit GLP-1 tablets could rise because pills are easier to fake than injectables.

Summary

Patients Face Cost

Patients cite cost as primary barrier, with 55% of insured GLP-1 users reporting affordability problems.
Uninsured patients face monthly GLP-1 prices of $900 to $1,400, prompting many to stop treatment.
Six percent of large employers dropped weight-loss GLP-1 coverage in 2026, per Bloomberg citing Cigna data.
Only 36% of employers cover GLP-1s for obesity, versus over 90% for diabetes, per 2026 survey.

1 of 2

Lilly Launches Pill

Eli Lilly launched the oral GLP-1 pill Foundayo in the United Kingdom on August 10, 2026.
Foundayo became available via private prescriptions at UK pharmacies on August 24, 2026.
Foundayo costs £100-£120 per month, compared with Lilly’s Mounjaro injection at £330.
NICE will decide on NHS coverage for Foundayo by 18 November 2026.
Pharmacists warned counterfeit GLP-1 tablets could rise because pills are easier to fake than injectables.

1 / 2